• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.活化的细胞毒性淋巴细胞通过增强3LL肿瘤细胞经由Fas信号传导介导髓源性抑制细胞趋化作用的能力来促进肿瘤进展。
Cell Mol Immunol. 2015 Jan;12(1):66-76. doi: 10.1038/cmi.2014.21. Epub 2014 Apr 28.
2
Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.Fas信号通过癌细胞衍生的前列腺素E2招募髓源性抑制细胞,从而促进肺癌生长。
J Immunol. 2009 Mar 15;182(6):3801-8. doi: 10.4049/jimmunol.0801548.
3
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.髓源性抑制细胞表达死亡受体 Fas,并在 T 细胞表达 FasL 时发生凋亡。
Blood. 2011 May 19;117(20):5381-90. doi: 10.1182/blood-2010-11-321752. Epub 2011 Mar 30.
4
Activated T cell exosomes promote tumor invasion via Fas signaling pathway.激活的 T 细胞外泌体通过 Fas 信号通路促进肿瘤侵袭。
J Immunol. 2012 Jun 15;188(12):5954-61. doi: 10.4049/jimmunol.1103466. Epub 2012 May 9.
5
Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.凋亡因子 Bcl-xL 和 Bax 的失调赋予髓源性抑制细胞抗凋亡能力,并有助于其在癌症中持续存在。
J Biol Chem. 2013 Jun 28;288(26):19103-15. doi: 10.1074/jbc.M112.434530. Epub 2013 May 15.
6
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.对Fas诱导的细胞凋亡敏感性降低的人细胞毒性T淋巴细胞。
Blood. 2005 Jun 15;105(12):4677-84. doi: 10.1182/blood-2004-08-3337. Epub 2005 Feb 15.
7
Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand.细胞毒性T淋巴细胞的最大增殖需要通过Fas配体进行反向信号传导。
J Exp Med. 1998 Jan 5;187(1):123-8. doi: 10.1084/jem.187.1.123.
8
Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.阻断乳腺癌细胞中的 Fas 信号通路通过破坏 Fas 信号通路引发的肿瘤相关炎症来抑制肿瘤生长和转移。
J Biol Chem. 2014 Apr 18;289(16):11522-11535. doi: 10.1074/jbc.M113.525014. Epub 2014 Mar 13.
9
CD8+ T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and, combined with GM‑CSF and IL‑12, enhance the anti‑renal cortical adenocarcinoma effect.外泌体来源的 RenCa 细胞刺激的 CD8+ T 细胞通过 FasL/Fas 信号通路介导特异性免疫反应,并与 GM-CSF 和 IL-12 联合增强抗肾皮质腺癌效应。
Oncol Rep. 2019 Aug;42(2):866-879. doi: 10.3892/or.2019.7208. Epub 2019 Jun 20.
10
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.肿瘤特异性细胞毒性T淋巴细胞(CTL)在体外利用穿孔素和Fas配体介导的细胞溶解作用杀伤小鼠肾癌细胞,但在体内,在没有穿孔素的情况下也能使肿瘤消退。
J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484.

引用本文的文献

1
Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization.血浆代谢物作为免疫细胞-胰腺癌风险的中介物:来自孟德尔随机化的见解。
Front Immunol. 2024 Jun 12;15:1402113. doi: 10.3389/fimmu.2024.1402113. eCollection 2024.
2
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer.综合分析确定了管腔B型乳腺癌的两个分子和临床亚组。
iScience. 2023 Jul 26;26(9):107466. doi: 10.1016/j.isci.2023.107466. eCollection 2023 Sep 15.
3
The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.与其他炎症生物标志物相比,术前血小板与中性粒细胞比值和淋巴细胞与单核细胞比值是卵巢癌更优的预后指标。
Front Immunol. 2023 Jun 30;14:1177403. doi: 10.3389/fimmu.2023.1177403. eCollection 2023.
4
Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer.天然红色素“灵菌红素”作为癌症免疫调节剂的兴起。
Cancer Cell Int. 2022 Dec 28;22(1):419. doi: 10.1186/s12935-022-02815-4.
5
The mechanisms on evasion of anti-tumor immune responses in gastric cancer.胃癌中抗肿瘤免疫反应逃逸的机制。
Front Oncol. 2022 Nov 10;12:943806. doi: 10.3389/fonc.2022.943806. eCollection 2022.
6
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition.区域输注 C 类 TLR9 激动剂增强肝脏肿瘤微环境重编程和 MDSC 减少,以提高对系统检查点抑制的反应性。
Cancer Gene Ther. 2022 Dec;29(12):1854-1865. doi: 10.1038/s41417-022-00484-z. Epub 2022 Jun 14.
7
Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.与雌性患有炎性乳腺癌的犬抗肿瘤免疫反应抑制相关的因素。
PLoS One. 2022 May 5;17(5):e0267648. doi: 10.1371/journal.pone.0267648. eCollection 2022.
8
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.肿瘤微环境对源自B细胞的淋巴样肿瘤的影响。
Diagnostics (Basel). 2022 Feb 23;12(3):573. doi: 10.3390/diagnostics12030573.
9
Surgery-mediated tumor-promoting effects on the immune microenvironment.手术介导的对免疫微环境的肿瘤促进作用。
Semin Cancer Biol. 2022 Nov;86(Pt 3):408-419. doi: 10.1016/j.semcancer.2022.01.006. Epub 2022 Jan 20.
10
Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.原位注射 CpG/αOX40/cGAMP 刺激 αPD-1 耐药性恶性肿瘤产生强大的免疫应答。
Cancer Immunol Immunother. 2022 Jul;71(7):1597-1609. doi: 10.1007/s00262-021-03095-z. Epub 2021 Nov 3.

本文引用的文献

1
Attacking malignant cells that survive therapy: Exploiting immunogenic modulation.攻击经治疗后存活的恶性细胞:利用免疫原性调节。
Oncoimmunology. 2013 Dec 1;2(12):e26937. doi: 10.4161/onci.26937. Epub 2013 Nov 6.
2
[Current research advance on cellular immunotherapy for leukemia-review].[白血病细胞免疫治疗的当前研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1326-30. doi: 10.7534/j.issn.1009-2137.2013.05.048.
3
Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy.肺癌患者针对免疫原性靶标的频繁 T 细胞反应可用于靶向免疫治疗。
Oncol Rep. 2014 Jan;31(1):384-90. doi: 10.3892/or.2013.2804. Epub 2013 Oct 23.
4
Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.过继细胞毒性 T 淋巴细胞疗法通过募集髓源性抑制细胞触发一种负调节性免疫抑制机制。
Int J Cancer. 2014 Apr 15;134(8):1810-22. doi: 10.1002/ijc.28506. Epub 2013 Oct 21.
5
COX2 regulation of breast cancer bone metastasis.环氧化酶2(COX2)对乳腺癌骨转移的调控
Oncoimmunology. 2013 Mar 1;2(3):e23129. doi: 10.4161/onci.23129.
6
Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.基因修饰树突状细胞来源的膜结合 TGF-β1 的外泌体可独立于 MHC 限制抑制小鼠 EAE。
Eur J Immunol. 2013 Sep;43(9):2461-72. doi: 10.1002/eji.201243295. Epub 2013 Jun 21.
7
Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.COX2 表达的调控控制着小鼠乳腺肿瘤细胞的骨转移和 PGE2 诱导调节性 T 细胞迁移。
PLoS One. 2012;7(9):e46342. doi: 10.1371/journal.pone.0046342. Epub 2012 Sep 28.
8
PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.PGE(2)- 驱动的癌症相关髓系来源的抑制性细胞的诱导和维持。
Immunol Invest. 2012;41(6-7):635-57. doi: 10.3109/08820139.2012.695417.
9
Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship.髓系来源的抑制细胞与抗肿瘤 T 细胞:复杂的关系。
Immunol Invest. 2012;41(6-7):595-613. doi: 10.3109/08820139.2012.673191.
10
Activated T cell exosomes promote tumor invasion via Fas signaling pathway.激活的 T 细胞外泌体通过 Fas 信号通路促进肿瘤侵袭。
J Immunol. 2012 Jun 15;188(12):5954-61. doi: 10.4049/jimmunol.1103466. Epub 2012 May 9.

活化的细胞毒性淋巴细胞通过增强3LL肿瘤细胞经由Fas信号传导介导髓源性抑制细胞趋化作用的能力来促进肿瘤进展。

Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

作者信息

Yang Fei, Wei Yinxiang, Cai Zhijian, Yu Lei, Jiang Lingling, Zhang Chengyan, Yan Huanmiao, Wang Qingqing, Cao Xuetao, Liang Tingbo, Wang Jianli

机构信息

1] Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China [2] The Second Affiliated Hospital, Hangzhou, Zhejiang, China.

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Cell Mol Immunol. 2015 Jan;12(1):66-76. doi: 10.1038/cmi.2014.21. Epub 2014 Apr 28.

DOI:10.1038/cmi.2014.21
PMID:24769795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4654365/
Abstract

The Fas/FasL system transmits intracellular apoptotic signaling, inducing cell apoptosis. However, Fas signaling also exerts non-apoptotic functions in addition to inducing tumor cell apoptosis. For example, Fas signaling induces lung cancer tumor cells to produce prostaglandin E2 (PGE2) and recruit myeloid-derived suppressor cells (MDSCs). Activated cytotoxic T lymphocytes (CTLs) induce and express high levels of FasL, but the effects of Fas activation initiated by FasL in CTLs on apoptosis-resistant tumor cells remain largely unclear. We purified activated CD8(+) T cells from OT-1 mice, evaluated the regulatory effects of Fas activation on tumor cell escape and investigated the relevant mechanisms. We found that CTLs induced tumor cells to secrete PGE2 and increase tumor cell-mediated chemoattraction of MDSCs via Fas signaling, which was favorable to tumor growth. Our results indicate that CTLs may participate in the tumor immune evasion process. To the best of our knowledge, this is a novel mechanism by which CTLs play a role in tumor escape. Our findings implicate a strategy to enhance the antitumor immune response via reduction of negative immune responses to tumors promoted by CTLs through Fas signaling.

摘要

Fas/FasL系统传递细胞内凋亡信号,诱导细胞凋亡。然而,Fas信号除了诱导肿瘤细胞凋亡外,还发挥非凋亡功能。例如,Fas信号诱导肺癌肿瘤细胞产生前列腺素E2(PGE2)并募集髓源性抑制细胞(MDSC)。活化的细胞毒性T淋巴细胞(CTL)诱导并高水平表达FasL,但FasL在CTL中引发的Fas激活对凋亡抗性肿瘤细胞的影响仍不清楚。我们从OT-1小鼠中纯化活化的CD8(+) T细胞,评估Fas激活对肿瘤细胞逃逸的调节作用,并研究相关机制。我们发现CTL通过Fas信号诱导肿瘤细胞分泌PGE2,并增加肿瘤细胞介导的MDSC趋化作用,这有利于肿瘤生长。我们的结果表明CTL可能参与肿瘤免疫逃逸过程。据我们所知,这是CTL在肿瘤逃逸中发挥作用的一种新机制。我们的发现暗示了一种策略,即通过减少CTL通过Fas信号促进的对肿瘤的负性免疫反应来增强抗肿瘤免疫反应。